Table of Contents Table of Contents
Previous Page  638 / 670 Next Page
Information
Show Menu
Previous Page 638 / 670 Next Page
Page Background

Fonterra Co-operative Group

Page 4

Introduction

The purpose of this report is to document the single laboratory validation (SLV) validation of an LC-MS/MS

method against SPIFAN matrices for the purposes of selection of the method as AOAC First Action and

recommendation to continue to Multi-Laboratory Validation (MLT).

Method

The LC-MS/MS method validated in this study is as published previously [3] for the analysis vitamin D

3

(cholecalciferol) in milk powder and infant formulas with additional method development to include

vitamin D

2

(ergocalciferol).

Principle

Samples are saponified at high temperature then lipid soluble components are extracted into isooctane. A

portion of the isooctane layer is transferred, washed, and an aliquot of 4-phenyl-1,2,4-triazoline-3,5-dione is

added to form the vitamin D adducts. The analytes are then re-extracted into a small volume of acetonitrile

and analysed by reverse-phase chromatography. Detection is by triple quadrupole mass spectrometer

using a selective transition: 572.2

Ѝ

298.0

m/z

for vitamin D

2

and 560.2

Ѝ

298.0

m/z

for vitamin D

3

. Internal

standards, deuterium-labelled vitamin D

2

(26,26,26,27,27,27-d6 ergocalciferol) or vitamin D

3

(26,26,26,27,27,27-d6 cholecalciferol) are used to correct for losses during extraction and variation in

derivatisation and ionisation efficiencies.

Validation

The method was initially developed and validated for the quantitation of vitamin D

3

in infant formulas and

fortified whole milk powders [3]. This study was undertaken to validate modifications to the original

published method to include vitamin D

2

and adult nutritional products within the method scope. The

validation protocol for inclusion in this report is based upon the SPIFAN SLV guidelines described

recently [1].

Samples

A range of infant formulas provided in the SPIFAN kit and in-house vitamin D

3

reference sample were used

in the evaluation of this method (Table 1). This SPIFAN kit was found during method validation to contain

no samples fortified with vitamin D

2

.

VitD-18 (February 2016)

FOR ERP USE ONLY

DO NOT DISTRIBUTE